| Cell line name |
UM-SCP-1 |
|---|
| Synonyms |
UMSCP-1; UMSCP1; University of Michigan-Squamous Cell carcinoma of the Prostate-1 |
|---|
| Accession |
CVCL_4906 |
|---|
| Resource Identification Initiative |
To cite this cell line use: UM-SCP-1 (RRID:CVCL_4906) |
|---|
| Comments |
Population: Caucasian.
Doubling time: ~36 hours (PubMed=6378378).
Derived from site: In situ; Prostate; UBERON=UBERON_0002367. |
|---|
| Disease |
Prostate squamous cell carcinoma (NCIt: C5536) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
71Y |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): PubMed=14518029
Markers:
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=6378378
Herbert Barton Grossman, Gary Wedemeyer, Li-Qin Ren, Thomas E. Carey;
UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma.
Cancer Res. 44:4111-4117(1984) PubMed=3335022
Michael C. Alley, Dominic A. Scudiero, Anne Monks, Miriam L. Hursey, Maciej J. Czerwinski, Donald L. Fine, Betty Jane Abbott, Joseph G. Mayo, Robert H. Shoemaker, Michael R. Boyd;
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
Cancer Res. 48:589-601(1988) PubMed=14518029; DOI=10.1002/pros.10290
Adrie van Bokhoven, Marileila Varella-Garcia, Christopher T. Korch, Widya U. Johannes, E. Erin Smith, Heidi L. Miller, Steven K. Nordeen, Gary J. Miller, M. Scott Lucia;
Molecular characterization of human prostate carcinoma cell lines.
Prostate 57:205-225(2003) CLPUB00698
Adrie van Bokhoven;
Models for prostate cancer. Molecular characterization and critical appraisal of human prostate carcinoma cell lines.
Thesis PhD (2004); Katholieke Universiteit Nijmegen; Nijmegen; Netherlands |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54990957
|
|---|
| Entry history |
|---|
| Entry creation | 04-Apr-2012 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 15 |
|---|
